TransBiotec Inc (OTC Pink - No Information:IMLE)

0.009
Delayed Data
As of Jun 22
 0.00 / 0.00%
Today’s Change
0.00
Today|||52-Week Range
0.02
+164.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-758.4K-744.6K-691.7K-595.1K
 
 
 
 
 
Depreciation777.00776.00454.000.00
 
 
 
 
Total Other Cash Flow-56.2K124.4K24.5K5.7K
 
 
 
 
 
Funds From Operations-813.8K-619.3K-666.8K-589.4K
 
 
 
 
 
Funds From/For Other Operating Expenses-369.1K-308.4K-224.8K-451.7K
 
 
 
 
 
Net Cash Flow - Operating Activities-444.7K-310.9K-441.9K-137.7K
 
 
 
 
 
 
InvestingFixed Asset Disposal511.000.000.000.00
 
 
Net Cash Flow Investing510.000.000.000.00
 
 
 
FinancingShort Term Borrowings----321.2K144.2K
 
 
 
Long Term Borrowings525.4K347.3K154.3K0.00
 
 
 
 
Long Term Debt Reduction-82.0K-35.7K-27.8K0.00
 
 
 
 
Net Proceeds Stock Sale0.000.001.5K0.00
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing443.4K311.5K449.2K144.2K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-790.00620.007.2K6.5K